Finance

Lists
JAGSNPHARM:NSE
Jagsonpal Pharmaceuticals Ltd
₹221,40
-1,85%
(-4,18) 1D
13 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for JAGSNPHARM...
Open
₹225,58
High
₹229,80
Low
₹219,80
Mkt. cap
14,63 mjd
Avg. vol.
425,87 k
Volume
96,67 k
Dividend
1,13%
Quarterly dividend
₹0,63
Ex-dividend date
04 Sep. 2026
P/E ratio
32,88
52-wk high
₹264,50
52-wk low
₹155,00
EPS
₹6,73
Shares outstanding
26,20 m
No. of employees
1 k
Open
₹225,58
High
₹229,80
Low
₹219,80
Mkt. cap
14,63 mjd
Avg. vol.
425,87 k
Volume
96,67 k
Dividend
1,13%
Quarterly dividend
₹0,63
Ex-dividend date
04 Sep. 2026
P/E ratio
32,88
52-wk high
₹264,50
52-wk low
₹155,00
EPS
₹6,73
Shares outstanding
26,20 m
No. of employees
1 k
News stories
From web sources and news partners
About Jagsonpal Pharmaceuticals Ltd
CEO-
Employees1,3 k
Founded1978
Headquarters-
SectorPharmaceutical industry
Last report
30 Jul. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
822,32 m / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
744,65 m
729,45 m
642,03 m
822,32 m
Cost of goods sold
272,28 m
264,53 m
249,67 m
286,24 m
Cost of revenue
272,28 m
264,53 m
249,67 m
286,24 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
165,46 m
172,95 m
397,81 m
227,78 m
Operating expense
331,89 m
326,10 m
303,96 m
385,10 m
Total operating expenses
604,17 m
590,63 m
553,63 m
671,34 m
Operating income
140,48 m
138,82 m
88,40 m
150,98 m
Other non operating income
30,27 m
29,75 m
-87,71 m
28,33 m
EBT including unusual items
168,10 m
145,21 m
117,56 m
176,80 m
EBT excluding unusual items
168,10 m
166,00 m
117,56 m
176,80 m
Income tax expense
42,36 m
35,70 m
29,94 m
44,91 m
Effective tax rate
25,20%
24,59%
25,47%
25,40%
Other operating expenses
126,28 m
126,45 m
-82,94 m
135,90 m
Net income
125,74 m
109,51 m
87,62 m
131,89 m
Net profit margin
16,89%
15,01%
13,65%
16,04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
117,43 m
-
Interest expense
-2,65 m
-2,57 m
-560,00 k
-2,51 m
Net interest expenses
-2,65 m
-2,57 m
116,87 m
-2,51 m
Depreciation and amortization charges
23,86 m
23,86 m
23,19 m
21,42 m
EBITDA
164,18 m
155,55 m
108,00 m
174,59 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme